Global Diabetes Device Market

Diabetes Device Market Size, Share, Growth Analysis, By Type (BGM Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use (Hospitals, Diagnostic Centers), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35B2125 | Region: Global | Published Date: December, 2025
Pages: 219 | Tables: 64 | Figures: 77

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Diabetes Device Market size was valued at USD 36.23 Billion in 2024 and is poised to grow from USD 39.42 Billion in 2025 to USD 77.4 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026–2033). 

    The competitive environment for diabetes treatment devices lists information per competitor. Information covered includes the company's executive summary, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production locations and facilities, production capacity, and application domination. Only the companies' focus on the market for diabetic care devices is represented by the data points mentioned above. 'Medtronic (Ireland) ', 'Abbott Laboratories (United States) ', 'DexCom (United States) ', 'Novo Nordisk (Denmark) ', 'Becton, Dickinson and Company (United States) ', 'Roche (Switzerland) ', 'Insulet (United States) ', 'Tandem Diabetes Care (United States) ', 'Ypsomed (Switzerland) ', 'Sanofi (France) ', 'Eli Lilly and Company (United States) ', 'LifeScan (United States) ', 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Bayer AG (Germany) ', 'Johnson & Johnson (United States) ', 'Terumo Corporation (Japan) ', 'AgaMatrix Holdings (United States) ', 'ARKRAY USA (United States) ', 'Nipro Corporation (Japan) '

    The rising prevalence of diabetes worldwide is a significant driver for the diabetes device market. Factors such as sedentary lifestyles, unhealthy dietary habits, obesity, and an aging population contribute to the growing incidence of diabetes. As the number of people diagnosed with diabetes increases, there is a higher demand for diabetes devices to manage and monitor the condition effectively.

    Insulin delivery systems, including insulin pumps and insulin pens, continue to evolve with advanced features and connectivity options. The market is witnessing a shift towards smart insulin delivery systems that integrate with CGM systems, allowing for automated insulin adjustments based on glucose readings. These systems offer enhanced convenience, precision, and personalized insulin delivery, contributing to improved glycaemic control.

    Due to its well-established healthcare industry, North America dominated the market in 2022 and is predicted to continue to do so with a growth rate of around 6.0% compound annual growth rate (CAGR) during the projected period. Along with technical developments and the introduction of new products, the rising incidence of obesity and the high cost of treatment are anticipated to drive the region. Due to a sizable diabetic population and advantageous reimbursement policies, the U.S. dominated the market in North America. The market is primarily driven by high per capita income and rising healthcare spending.

    Related Reports

    Diabetes Care Devices Market
    Buy Now GET FREE SAMPLE
    Diabetes Care Devices and Drugs Market
    Buy Now GET FREE SAMPLE
    Blood Glucose Monitoring Devices Market
    Buy Now GET FREE SAMPLE
    Insulin Storage Devices Market
    Buy Now GET FREE SAMPLE
    Continuous Glucose Monitoring Devices Market
    Buy Now GET FREE SAMPLE
    Smart Diabetes Management Market
    Buy Now GET FREE SAMPLE
    Human Insulin Market
    Buy Now GET FREE SAMPLE
    Insulin Pump Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Diabetes Device Market

    Report ID: SQMIG35B2125

    $5,300
    BUY NOW GET FREE SAMPLE